Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity

Jiabin An1, Matthew B Rettig

  • 1Division of Hematology/Oncology, Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System-West Los Angeles, CA 90073, USA.

Insights

Clear cell renal cell carcinoma (CCRCC) involves von Hippel-Lindau (VHL) gene mutations, leading to hypoxia-inducible factor alpha (HIFalpha) accumulation. This study reveals VHL loss activates nuclear factor kappa B (NF-kappaB) via HIFalpha, driving tumor growth and offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Biallelic inactivating mutations in the von Hippel-Lindau tumor suppressor gene (VHL) are characteristic of clear cell renal cell carcinoma (CCRCC).
  • VHL gene inactivation leads to the accumulation of hypoxia-inducible factor alpha (HIFalpha).
  • The precise downstream targets of HIFalpha driving renal carcinogenesis remain incompletely understood.

Purpose of the Study:

  • To elucidate the downstream molecular mechanisms by which VHL loss promotes renal carcinogenesis.
  • To investigate the role of hypoxia-inducible factor alpha (HIFalpha) and nuclear factor kappa B (NF-kappaB) signaling in VHL-deficient tumors.
  • To identify potential therapeutic targets within the VHL-NF-kappaB pathway in CCRCC.

Main Methods:

  • Analysis of VHL inactivation and its effect on HIFalpha accumulation.
  • Investigating the induction of nuclear factor kappa B (NF-kappaB) signaling downstream of HIFalpha.
  • Utilizing cell culture models to study the VHL-HIFalpha-NF-kappaB signaling cascade and its impact on tumor cell growth.

Main Results:

  • VHL loss induces HIFalpha accumulation, which in turn activates nuclear factor kappa B (NF-kappaB).
  • HIFalpha induces the expression of transforming growth factor alpha, initiating an EGFR/PI3K/AKT/IKKα/NF-kappaB signaling cascade.
  • Components of this identified signaling pathway are crucial for the proliferation of VHL-deficient tumor cells.

Conclusions:

  • VHL inactivation in CCRCC activates NF-kappaB signaling through HIFalpha accumulation.
  • The identified EGFR/PI3K/AKT/IKKα/NF-kappaB pathway is a key driver of tumor growth in VHL-deficient renal cancer.
  • Targeting components of this pathway presents a promising therapeutic strategy for VHL-mutated CCRCC.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...